Aplenzin (Valeant Pharmaceuticals North America LLC)


Welcome to the PulseAid listing for the Aplenzin drug offered from Valeant Pharmaceuticals North America LLC. This Aminoketone [EPC],Dopamine Uptake Inhibitors [MoA],Increased Dopamine Activity [PE],Increased Norepinephrine Activity [PE],Norepinephrine Uptake Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Valeant Pharmaceuticals North America LLC
NON-PROPRIETARY NAME: bupropion hydrobromide
SUBSTANCE NAME: BUPROPION HYDROBROMIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Aminoketone [EPC],Dopamine Uptake Inhibitors [MoA],Increased Dopamine Activity [PE],Increased Norepinephrine Activity [PE],Norepinephrine Uptake Inhibitors [MoA]
ROUTE: ORAL
DOSAGE FORM: TABLET, EXTENDED RELEASE
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2008-04-23
END MARKETING DATE: 0000-00-00


Aplenzin HUMAN PRESCRIPTION DRUG Details:

Item DescriptionAplenzin from Valeant Pharmaceuticals North America LLC
LABELER NAME: Valeant Pharmaceuticals North America LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 174(mg/1)
START MARKETING DATE: 2008-04-23
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0187-5810_95691d90-1d22-4a8d-8b9d-82a9dbc04110
PRODUCT NDC: 0187-5810
APPLICATION NUMBER: NDA022108

Other BUPROPION HYDROBROMIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
sanofi-aventis U.S. LLCAplenzin
STAT RX USA LLCAPLENZIN
Valeant Pharmaceuticals North America LLCAplenzin